Home › Asset managers › Compare 2025-2026 › Vanguard vs Charles Schwab
Vanguard 2025-2026 · Charles Schwab 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 33,754 | 30,065 | 1,248 | 2,441 | 96.0% | 93.8% |
| Board proposals | 30,259 | 26,946 | 1,155 | 2,158 | 95.9% | 93.7% |
| E&S shareholder proposals | 192 | 164 | 5 | 23 | 97.0% | 96.0% |
| Other items | 3,303 | 2,955 | 88 | 260 | 97.1% | 94.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
3,313 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Vanguard | Charles Schwab |
|---|---|---|---|---|---|---|
| AIRGAIN INC | June 10, 2026 | To approve the amendment and restatement of the 2016 Incentive Award Plan. Compensation |
Board | For | Split 2 FOR, 1 AGAINST |
FOR 1 fund |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | Split 17 FOR, 6 AGAINST |
FOR 14 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | Split 22 FOR, 6 AGAINST |
FOR 16 funds |
| AKEBIA THERAPEUTICS, INC. | June 17, 2026 | Elect Michael Rogers Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 3 funds |
| AKERO THERAPEUTICS, INC | December 2, 2025 | To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. Say-on-Pay |
Board | Contested | Split 15 FOR, 1 AGAINST |
FOR 5 funds |
| ALDEYRA THERAPEUTICS, INC. | June 9, 2026 | Election of Class III Director: Todd C. Brady, M.D., Ph.D. Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 2 funds |
| ALECTOR, INC. | June 17, 2026 | Elect Elizabeth A. Garofalo Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 4 funds |
| ALEXANDER'S, INC. | May 21, 2026 | Non-Binding Advisory Resolution on Executive Compensation. Say-on-Pay |
Board | For | Split 17 FOR, 1 AGAINST |
FOR 7 funds |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | May 13, 2026 | To cast a non-binding, advisory vote on a resolution to approve the compensation of the Company's named executive officers, as more particularly described in the accompanying Proxy Statement. Say-on-Pay |
Board | For | Split 24 FOR, 4 AGAINST |
FOR 17 funds |
| ALIGHT, INC. | June 10, 2026 | To approve, on an advisory (non-binding) basis, the 2025 compensation paid to our named executive officers. Say-on-Pay |
Board | For | Split 20 FOR, 2 AGAINST |
FOR 6 funds |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | Advisory Vote to Approve the Compensation of our Named Executive Officers Say-on-Pay |
Board | For | Split 28 FOR, 7 AGAINST |
FOR 15 funds |
| ALKERMES PLC | May 20, 2026 | To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. Compensation |
Board | For | Split 25 FOR, 5 AGAINST |
FOR 8 funds |
| ALLEGRO MICROSYSTEMS, INC. | August 7, 2025 | To approve, on an advisory basis, the Company's executive compensation. Say-on-Pay |
Board | For | Split 23 FOR, 3 AGAINST |
FOR 11 funds |
| ALLOGENE THERAPEUTICS, INC. | June 18, 2026 | To approve an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock from 400,000,000 shares to 800,000,000 shares. Capital Structure |
Board | For | Split 10 FOR, 2 AGAINST |
FOR 4 funds |
| ALLY FINANCIAL INC. | May 6, 2026 | Approval of the Ally Financial Inc. Incentive Compensation Omnibus Plan. Compensation |
Board | For | Split 28 FOR, 1 AGAINST |
FOR 13 funds |
| ALNYLAM PHARMACEUTICALS, INC. | May 20, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 30 FOR, 3 AGAINST |
FOR 9 funds |
| ALPHABET INC. | June 5, 2026 | Advisory vote to approve compensation awarded to named executive officers Say-on-Pay |
Board | For | Split 26 FOR, 29 AGAINST |
AGAINST 19 funds |
| ALPHABET INC. | June 5, 2026 | Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stock Compensation |
Board | For | Split 39 FOR, 9 AGAINST |
FOR 16 funds |
| ALPHABET INC. | June 5, 2026 | Ratification of appointment of Ernst & Young LLP as Alphabet's independent registered public accounting firm for the fiscal year ending December 31, 2026 Audit-related |
Board | For | Split 51 FOR, 1 AGAINST |
FOR 16 funds |
| ALTA EQUIPMENT GROUP INC. | May 29, 2026 | To approve the First Amendment to Alta Equipment Group, Inc 2020 Omnibus Incentive Plan Compensation |
Board | For | Split 7 FOR, 3 AGAINST |
FOR 2 funds |
| ALTI GLOBAL, INC. | June 17, 2026 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2026. Audit-related |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 4 funds |
| ALTIMMUNE INC. | April 16, 2026 | Elect John M. Gill Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 2 funds |
| ALTIMMUNE INC. | April 16, 2026 | Elect Klaus O. Schafer Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 2 funds |
| ALTIMMUNE INC. | April 16, 2026 | Elect Mitchel B. Sayare Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 2 funds |
| ALTIMMUNE INC. | April 16, 2026 | Elect Wayne Pisano Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 2 funds |
| ALTO NEUROSCIENCE, INC. | May 12, 2026 | To approve an amendment and restatement of the Company's 2024 Employee Stock Purchase Plan to treat outstanding pre-funded warrants the same as outstanding shares of Common Stock for purposes of calculating the number of shares to be automatically added to the share reserve thereunder pursuant to the "evergreen" feature of the 2024 Employee Stock Purchase Plan. Capital Structure |
Board | For | Split 3 FOR, 1 AGAINST |
AGAINST 1 fund |
| AMAZON.COM, INC. | May 20, 2026 | RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS Audit-related |
Board | For | Split 48 FOR, 2 AGAINST |
FOR 15 funds |
| AMBARELLA, INC. | June 26, 2026 | To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan. Compensation |
Board | For | Split 15 FOR, 1 AGAINST |
AGAINST 5 funds |
| AMC GLOBAL MEDIA INC. | June 16, 2026 | Elect Matthew C. Blank Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 8 funds |
| AMC GLOBAL MEDIA INC. | June 16, 2026 | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2026 Audit-related |
Board | For | Split 10 FOR, 1 AGAINST |
FOR 8 funds |
| AMDOCS LIMITED | January 30, 2026 | To ratify and approve the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2026, and until the next annual general meeting, and authorize the Audit Committee of the Board of Directors to fix the remuneration of such independent registered public accounting firm in accordance with the nature and extent of its services (Proposal V). Audit-related |
Board | For | Split 5 FOR, 1 AGAINST |
FOR 7 funds |
| AMERANT BANCORP INC. | June 2, 2026 | Election of Director to serve until the 2027 annual meeting of shareholders: Erin D. Knight Director Elections |
Board | For | Split 2 FOR, 2 AGAINST |
FOR 5 funds |
| AMERANT BANCORP INC. | June 2, 2026 | Election of Director to serve until the 2027 annual meeting of shareholders: Oscar Suarez Director Elections |
Board | For | Split 2 FOR, 2 AGAINST |
FOR 5 funds |
| AMERICAN AIRLINES GROUP INC. | June 10, 2026 | A proposal to approve, on a non-binding, advisory basis, executive compensation as disclosed in the Proxy Statement for the 2026 Annual Meeting of Stockholders Say-on-Pay |
Board | For | Split 29 FOR, 5 AGAINST |
FOR 14 funds |
| AMERICAN ASSETS TRUST, INC. | June 1, 2026 | Elect Robert S. Sullivan Director Elections |
Board | For | Split 4 FOR, 4 WITHHOLD |
FOR 11 funds |
| AMERICAN ASSETS TRUST, INC. | June 1, 2026 | Elect Thomas S. Olinger Director Elections |
Board | For | Split 4 FOR, 4 WITHHOLD |
FOR 11 funds |
| AMERICAN EXPRESS COMPANY | May 5, 2026 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | Split 42 FOR, 4 AGAINST |
FOR 16 funds |
| AMERICAN INTERNATIONAL GROUP, INC. | May 13, 2026 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | Split 43 FOR, 5 AGAINST |
FOR 13 funds |
| AMERICAN INTERNATIONAL GROUP, INC. | May 13, 2026 | Ratify Appointment of PricewaterhouseCoopers LLP to Serve as Independent Auditor for 2026. Audit-related |
Board | For | Split 33 FOR, 9 AGAINST |
FOR 12 funds |
| AMERICOLD REALTY TRUST, INC. | May 18, 2026 | Ratification of Ernst & Young LLP as our Independent Accounting Firm for 2026. Audit-related |
Board | For | Split 16 FOR, 2 AGAINST |
FOR 11 funds |
| AMERIPRISE FINANCIAL, INC. | April 29, 2026 | To approve the compensation of the named executive officers by a nonbinding advisory vote. Say-on-Pay |
Board | For | Split 32 FOR, 11 AGAINST |
FOR 16 funds |
| AMICUS THERAPEUTICS, INC. | March 3, 2026 | To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | Split 16 FOR, 1 AGAINST |
FOR 5 funds |
| AMN HEALTHCARE SERVICES, INC. | May 1, 2026 | To approve, by non-binding advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | Split 21 FOR, 4 AGAINST |
AGAINST 8 funds |
| AMPLIFY ENERGY CORP. | June 3, 2026 | To approve the Amplify Energy Corp. 2024 Amended and Restated Equity Incentive Plan. Compensation |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 1 fund |
| AMPLITUDE, INC. | June 9, 2026 | Elect Catherine Wong Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 3 funds |
| AMPLITUDE, INC. | June 9, 2026 | Elect Curtis Liu Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 3 funds |
| AMPLITUDE, INC. | June 9, 2026 | Elect Patrick Grady Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 3 funds |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 16 FOR, 1 AGAINST |
FOR 5 funds |
| ANALOG DEVICES, INC. | March 11, 2026 | Approve the Amended and Restated Analog Devices, Inc. 2020 Equity Incentive Plan. Compensation |
Board | For | Split 31 FOR, 6 AGAINST |
FOR 12 funds |
| ANDERSEN GROUP INC. | June 22, 2026 | To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 1 fund |
| ANGI INC. | June 10, 2026 | Approval of the Amended and Restated Angi Inc. 2017 Stock and Annual Incentive Plan. Compensation |
Board | For | Split 10 FOR, 1 AGAINST |
FOR 7 funds |
| ANGI INC. | June 10, 2026 | Elect Sandra Buchanan Hurse Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 7 funds |
| ANGI INC. | June 10, 2026 | Ratification of the appointment of Ernst & Young LLP as Angi Inc.'s independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | Split 10 FOR, 1 AGAINST |
FOR 7 funds |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | Split 14 FOR, 4 AGAINST |
FOR 6 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Approval of the Amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. Compensation |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 4 funds |
| ANNEXON, INC. | June 11, 2026 | Elect Bettina M. Cockroft Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 4 funds |
| ANNEXON, INC. | June 11, 2026 | Elect Douglas E. Love Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 4 funds |
| ANTERIX INC. | August 5, 2025 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 17 FOR, 1 AGAINST |
FOR 5 funds |
| AON PLC | June 26, 2026 | Advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 17 FOR, 12 AGAINST |
AGAINST 15 funds |
| APPIAN CORPORATION | June 3, 2026 | Elect Mark Lynch Director Elections |
Board | For | Split 3 FOR, 3 WITHHOLD |
FOR 5 funds |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | October 21, 2025 | Election of Directors: Mary Dean Hall Director Elections |
Board | For | Split 20 FOR, 1 WITHHOLD |
WITHHOLD 12 funds |
| APPLIED MATERIALS, INC. | March 12, 2026 | Ratification of the appointment of KPMG LLP as Applied Materials' independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | Split 36 FOR, 1 AGAINST |
FOR 13 funds |
| APPLIED OPTOELECTRONICS, INC. | June 4, 2026 | To approve the 2026 equity incentive plan. Compensation |
Board | For | Split 13 FOR, 2 AGAINST |
AGAINST 4 funds |
| APPLOVIN CORPORATION | June 3, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 43 FOR, 2 AGAINST |
FOR 14 funds |
| APTARGROUP, INC. | May 6, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | Split 24 FOR, 4 AGAINST |
FOR 13 funds |
| APTIV PLC | April 29, 2026 | Proposal to re-appoint auditors, ratify independent public accounting firm and authorize the directors to determine the fees paid to the auditors. Audit-related |
Board | For | Split 26 FOR, 7 AGAINST |
FOR 12 funds |
| ARBOR REALTY TRUST, INC. | May 20, 2026 | Advisory vote to approve the compensation of Arbor Realty Trust, Inc.'s named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | Split 1 FOR, 24 AGAINST |
AGAINST 8 funds |
| ARBUTUS BIOPHARMA CORPORATION | May 26, 2026 | To approve the adoption of the Arbutus Biopharma Corporation 2026 Omnibus Share and Incentive Plan; Compensation |
Board | For | Split 9 FOR, 2 AGAINST |
FOR 5 funds |
| ARCHER AVIATION INC. | June 26, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 14 FOR, 1 AGAINST |
AGAINST 7 funds |
| ARCTURUS THERAPEUTICS, HOLDINGS INC. | June 5, 2026 | Elect Jing L. Marantz Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 4 funds |
| ARCTURUS THERAPEUTICS, HOLDINGS INC. | June 5, 2026 | Elect John H. Markels Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 4 funds |
| ARCTURUS THERAPEUTICS, HOLDINGS INC. | June 5, 2026 | Elect Joseph E. Payne Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 4 funds |
| ARCTURUS THERAPEUTICS, HOLDINGS INC. | June 5, 2026 | Elect Magda Marquet Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 4 funds |
| ARCTURUS THERAPEUTICS, HOLDINGS INC. | June 5, 2026 | Elect Peter C. Farrell Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 4 funds |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Patrick J. Heron Director Elections |
Board | For | Split 13 FOR, 1 WITHHOLD |
FOR 5 funds |
| ARDAGH METAL PACKAGING S.A. | June 4, 2026 | Appoint PricewaterhouseCoopers Assurance, Societe cooperative as statutory auditor (reviseur d'entreprises agree) of the Company for the period ending at the 2027 annual general meeting of shareholders. Audit-related |
Board | For | Split 2 FOR, 1 AGAINST |
FOR 4 funds |
| ARDELYX, INC | June 16, 2026 | Elect Robert B. Bazemore Jr. Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 5 funds |
| ARDELYX, INC | June 16, 2026 | To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. Compensation |
Board | For | Split 10 FOR, 5 AGAINST |
FOR 5 funds |
| ARES MANAGEMENT CORPORATION | June 8, 2026 | The ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for our 2026 fiscal year. Audit-related |
Board | For | Split 24 FOR, 10 AGAINST |
FOR 16 funds |
| ARISTA NETWORKS, INC. | May 29, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 39 FOR, 2 AGAINST |
AGAINST 15 funds |
| ARKO CORP. | June 4, 2026 | Elect Arie Kotler Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 7 funds |
| ARM HOLDINGS PLC | September 9, 2025 | To re-elect Jeffrey A. Sine as a director of the Company, who is retiring in accordance with the Company's articles of association and, being eligible, is offering himself for re- election. Director Elections |
Board | None | Split 3 FOR, 2 AGAINST |
FOR 2 funds |
| ARM HOLDINGS PLC | September 9, 2025 | To re-elect Masayoshi Son as a director of the Company, who is retiring in accordance with the Company's articles of association and, being eligible, is offering himself for re- election. Director Elections |
Board | None | Split 1 FOR, 4 AGAINST |
FOR 2 funds |
| ARM HOLDINGS PLC | September 9, 2025 | To re-elect Paul E. Jacobs as a director of the Company, who is retiring in accordance with the Company's articles of association and, being eligible, is offering himself for re- election. Director Elections |
Board | None | Split 3 FOR, 2 AGAINST |
AGAINST 2 funds |
| ARM HOLDINGS PLC | September 9, 2025 | To re-elect Rene Haas as a director of the Company, who is retiring in accordance with the Company's articles of association and, being eligible, is offering himself for re- election. Director Elections |
Board | None | Split 3 FOR, 2 AGAINST |
FOR 2 funds |
| ARM HOLDINGS PLC | September 9, 2025 | To re-elect Ronald D. Fisher as a director of the Company, who is retiring in accordance with the Company's articles of association and, being eligible, is offering himself for re- election. Director Elections |
Board | None | Split 3 FOR, 2 AGAINST |
FOR 2 funds |
| ARMOUR RESIDENTIAL REIT, INC. | April 30, 2026 | To approve, by non-binding advisory vote, ARMOUR's 2025 executive compensation. Say-on-Pay |
Board | For | Split 26 FOR, 5 AGAINST |
FOR 5 funds |
| ARRAY DIGITAL INFRASTRUCTURE, INC. | October 9, 2025 | Election of Directors: E. C. Iriarte Director Elections |
Board | For | Split 6 FOR, 1 WITHHOLD |
FOR 6 funds |
| ARRAY DIGITAL INFRASTRUCTURE, INC. | October 9, 2025 | Election of Directors: H. J. Harczak, Jr. Director Elections |
Board | For | Split 6 FOR, 1 WITHHOLD |
WITHHOLD 6 funds |
| ARRAY DIGITAL INFRASTRUCTURE, INC. | October 9, 2025 | Election of Directors: X. D. Williams Director Elections |
Board | For | Split 6 FOR, 1 WITHHOLD |
FOR 6 funds |
| ARROW ELECTRONICS, INC. | May 12, 2026 | To ratify the appointment of Ernst & Young LLP as Arrow's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 20 FOR, 7 AGAINST |
FOR 12 funds |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | Split 9 FOR, 18 AGAINST |
AGAINST 6 funds |
| ARS PHARMACEUTICALS, INC. | June 24, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | Split 13 FOR, 1 AGAINST |
FOR 5 funds |
| ARTHUR J. GALLAGHER & CO. | May 12, 2026 | Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers. Say-on-Pay |
Board | For | Split 32 FOR, 9 AGAINST |
FOR 16 funds |
| ARVINAS, INC. | June 24, 2026 | Elect Leslie V. Norwalk Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 4 funds |
| ASANA, INC. | June 8, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers ("Say-on-Pay"). Say-on-Pay |
Board | For | Split 20 FOR, 5 AGAINST |
AGAINST 6 funds |
| ASANA, INC. | June 8, 2026 | Elect Krista Anderson-Copperman Director Elections |
Board | For | Split 3 FOR, 3 WITHHOLD |
FOR 5 funds |
| ASML Holding N.V. | April 22, 2026 | Elect Terri L. Kelly to the Supervisory Board Director Elections |
Board | For | Split 4 FOR, 2 AGAINST |
FOR 6 funds |
| ASML Holding N.V. | April 22, 2026 | Remuneration Report Compensation |
Board | For | Split 4 FOR, 2 AGAINST |
FOR 6 funds |
| ASPEN AEROGELS, INC. | May 13, 2026 | Approval, on a non-binding, advisory basis, of the compensation of Aspen Aerogels, Inc.'s named executive officers, as disclosed in its Proxy Statement for the 2026 Annual Meeting. Say-on-Pay |
Board | For | Split 13 FOR, 1 AGAINST |
FOR 5 funds |
← Previous Page 13 of 34 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.